Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120

Journal of Neurochemistry

Volumn 120, Issue 1, 2012, Pages 106-114

  Lisi, Lucia ^a   Tramutola, Antonella ^a   De Luca, Andrea ^a,b   Navarra, Pierluigi ^a   Dello Russo, Cinzia ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

CCR5 receptor antagonist; cyclo oxygenase; gp 120; maraviroc; microglia; nitric oxide synthase

Indexed keywords

CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; GLYCOPROTEIN GP 120; MARAVIROC;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BRAIN CELL; CONTROLLED STUDY; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS; MACROPHAGE; MICROGLIA; NERVE CELL STIMULATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; CYCLOHEXANES; CYTOKINES; DINOPROSTONE; DNA PRIMERS; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; INFLAMMATION; INTERFERON-GAMMA; MACROPHAGE ACTIVATION; MICROGLIA; NITRIC OXIDE; RATS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CCR5; RNA, MESSENGER; TRIAZOLES;

HUMAN IMMUNODEFICIENCY VIRUS 1; RATTUS;

EID: 83855165646     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07549.x     Document Type: Article

References (31)

1. Blanpain C., Doranz B. J., Bondue A., Govaerts C., De Leener A., Vassart G., Doms R. W., Proudfoot A., and, Parmentier M., (2003) The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle. J. Biol. Chem. 278, 5179-5187. (Pubitemid 36801030)
2. Capuano A., De Corato A., Lisi L., Tringali G., Navarra P., and, Dello Russo C., (2009) Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology. Mol. Pain 5, 43.
3. Chen X., Choi I. Y., Chang T. S., Noh Y. H., Shin C. Y., Wu C. F., Ko K. H., and, Kim W. K., (2009) Pretreatment with interferon-gamma protects microglia from oxidative stress via up-regulation of Mn-SOD. Free Radic. Biol. Med. 46, 1204-1210.
4. Dello Russo C., Lisi L., Tringali G., and, Navarra P., (2009a) Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation. Biochem. Pharmacol. 78, 1242-1251.
5. Dello Russo C., Lisi L., Navarra P., and, Tringali G., (2009b) Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes. J. Neuroimmunol. 213, 78-83.
6. Dorr P., Westby M., Dobbs S., et al. (2005) Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob. Agents Chemother. 49, 4721-4732. (Pubitemid 41552605)
7. Feng T. T., Zhao G., Yao H. P., Wang Q. P., and, Wu N. P., (2009) Expression and identification of immunological activities of the HIV-gp120N-human interferon gamma fusion protein. Anat. Rec. (Hoboken) 292, 381-386.
8. Ferain T., Hoveyda H. R., Ooms F., Schols D., Bernard J., and, Fraser G., (2011) Agonist-induced internalization of CCR5 as a mechanism to inhibit HIV replication. J. Pharmacol. Exp. Ther. 377, 655-662.
9. Gamo K., Kiryu-Seo S., Konishi H., Aoki S., Matsushima K., Wada K., and, Kiyama H., (2008) G-protein-coupled receptor screen reveals a role for chemokine receptor CCR5 in suppressing microglial neurotoxicity. J. Neurosci. 28, 11980-11988.
10. Garcaa-Tuñõn I., Ricote M., Ruiz A. A., Fraile B., Paniagua R., and, Royuela M., (2007) Influence of IFN-gamma and its receptors in human breast cancer. BMC Cancer 7, 1-11.
11. Gilliam B. L., Riedel D. J., and, Redfield R. R., (2010) Clinical use of CCR5 inhibitors in HIV and beyond. J. Transl. Med. 9 (Suppl. 1), S9.
12. Gorry P. R., Bristol G., Zack J. A., et al. (2001) Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J. Virol. 75, 10073-10089. (Pubitemid 32948038)
13. Grovit-Ferbas K., and, Harris-White M. E., (2010) Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction. Immunol. Res. 48, 40-58.
14. Häusler K. G., Priz M., Nolte C., Weber J. R., Schumann R. R., Kettenmann H., and, Hanisch U., (2002) Interferon-γ differentially modulates the release of cytokines nad chemokines in lipopolysaccharide and pneumococcal cell wall-stimulated mouse microglia and macrophages. Eur. J. Neurosci. 16, 2113-2122. (Pubitemid 35454255)
15. Hosking M. P., and, Lane T. E., (2010) The role of chemokines during viral infection of the CNS. PLoS Pathog. 29, 1-4 (review).
16. Jiang Y., Salafranca M. N., Adhikari S., Xia Y., Feng L., Sonntag M. K., deFiebre C. M., Pennell N. A., Streit W. J., and, Harrison J. K., (1998) Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis. J. Neuroimmunol. 86, 1-12. (Pubitemid 28293944)
17. Kedzierska K., Crowe S. M., Turville S., and, Cunningham A. L., (2003) The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages. Rev. Med. Virol. 13, 39-56 (review). (Pubitemid 36125504)
18. Kong L. Y., Wilson B. C., McMillian M. K., Bing G., Hudson P. M., and, Hong J. S., (1996) The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Cell. Immunol. 25, 77-83. (Pubitemid 26295665)
19. Ledeboer A., Brevé J. J., Poole S., Tilders F. J., and, Van Dam A. M., (2000) Interleukin-10, interleukin-4, and transforming growth factor-beta differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells. Glia 30, 134-142. (Pubitemid 30199427)
20. Lisi L., Navarra P., Feinstein D. L., and, Dello Russo C., (2011) The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes. J. Neuroinflammation 8, 1-10.
21. Louboutin J. P., Reyes B. A., Agrawal L., Van Bockstaele E. J., and, Strayer D. S., (2010) HIV-1 gp120-induced neuroinflammation: relationship to neuron loss and protection by rSV40-delivered antioxidant enzymes. Exp. Neurol. 221, 231-245.
22. Maurer M., and, von Stebut E., (2004) Macrophage inflammatory protein-1. Int. J. Biochem. Cell Biol., 36, 1882-1886. (Pubitemid 38760018)
23. Moore J. P., and, Kuritzkes D. R., (2009) A piace de resistance: how HIV-1 escapes small molecule CCR5 inhibitors. Curr. Opin. HIV AIDS 4, 118-124 (review).
24. Norris P. J., Pappalardo B. L., Custer B., Spotts G., Hecht F. M., and, Busch M. P., (2006) Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection. AIDS Res. Hum. Retroviruses 22, 757-762. (Pubitemid 44735002)
25. Rock R. B., Hu S., Deshpande A., Munir S., May B. J., Baker C. A., Peterson P. K., and, Kapur V., (2005) Transcriptional response of human microglial cells to interferon-gamma. Genes Immun. 6, 712-9. (Pubitemid 41741717)
26. Shapshak P., Duncan R., Minagar A., Rodriguez de la Vega P., Stewart R. V., and, Goodkin K., (2004) Elevated expression of IFN-gamma in the HIV-1 infected brain. Front. Biosci. 9, 1073-81. (Pubitemid 39060830)
27. Vairano M., Dello Russo C., Pozzoli G., Battaglia A., Scambia G., Tringali G., Aloe-Spiriti M. A., Preziosi P., and, Navarra P., (2002) Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro. Eur. J. Neurosci. 16, 584-592.
28. Walker D. K., Bowers S. J., Mitchell R. J., Potchoiba M. J., Schroeder C. M., and, Small H. F., (2008) Preclinical assessment of the distribution of maraviroc to potential human immunodeficiency virus (HIV) sanctuary sites in the central nervous system (CNS) and gut-associated lymphoid tissue (GALT). Xenobiotica 38, 1330-1339.
29. Wang Y., Li M., Song M., Xu X., Xiong J., Yang X., Tan J., and, Bai Y., (2008) Expression of OX40 ligand in microglia activated by IFN-gamma sustains a protective CD4 + T-cell response in vitro. Cell. Immunol. 251, 86-92.
30. Wells T. N. C., Power C. A., Shaw J. P., and, Proudfoot A.E. I., (2006) Chemokine blockers-therapeutics in the making? Trends Pharmacol. Sci. 27, 41-47. (Pubitemid 43063123)
31. Yadav A., and, Collman R.G., (2009) CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. J. Neuroimmune Pharmacol. 4, 430-447.